☆ 4.3 Letter

Letter to the Editor Regarding Erythropoietin-Stimulating Agents Resistance in Haemodialysis-Treated Patients: Time for a Treatment Shift?

HEART LUNG AND CIRCULATION (2023)

Journal

HEART LUNG AND CIRCULATION

Volume 32, Issue 8, Pages e53-e54

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.hlc.2023.05.007

Keywords

Erythropoietin-stimulating agents; Chronic kidney disease; Anaemia; Cardiovascular disease; Mortality

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.